These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11087323)

  • 1. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy.
    Polyakov V; Sharma V; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
    Bioconjug Chem; 2000; 11(6):762-71. PubMed ID: 11087323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy.
    Bullok KE; Dyszlewski M; Prior JL; Pica CM; Sharma V; Piwnica-Worms D
    Bioconjug Chem; 2002; 13(6):1226-37. PubMed ID: 12440857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation peptide conjugates for in vivo molecular imaging applications.
    Bullok KE; Gammon ST; Violini S; Prantner AM; Villalobos VM; Sharma V; Piwnica-Worms D
    Mol Imaging; 2006; 5(1):1-15. PubMed ID: 16779965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOTA and NODAGA [
    Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of Re/
    Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
    Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins.
    Ocampo-García BE; Santos-Cuevas CL; De León-Rodríguez LM; García-Becerra R; Ordaz-Rosado D; Luna-Guitiérrez MA; Jiménez-Mancilla NP; Romero-Piña ME; Ferro-Flores G
    Nucl Med Biol; 2013 May; 40(4):481-7. PubMed ID: 23618768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
    Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
    Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes.
    Yang F; Wang K; Zhou K; Dai B; Dai J; Liang Y; Cui M
    Eur J Med Chem; 2019 Sep; 177():291-301. PubMed ID: 31158745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Versatile synthetic approach to new bifunctional chelating agents tailor made for labeling with the fac-[M(CO)(3)](+) core (M = Tc, (99m)Tc, Re): synthesis, in vitro, and in vivo behavior of the model complex [M(APPA)(CO)(3)] (APPA = [(5-amino-pentyl)-pyridin-2-yl-methyl-amino]-acetic acid).
    Stichelberger A; Waibel R; Dumas C; Schubiger PA; Schibli R
    Nucl Med Biol; 2003 Jul; 30(5):465-70. PubMed ID: 12831983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties.
    Smith CJ; Gali H; Sieckman GL; Higginbotham C; Volkert WA; Hoffman TJ
    Bioconjug Chem; 2003; 14(1):93-102. PubMed ID: 12526698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.
    Zhang YM; Tung CH; He J; Liu N; Yanachkov I; Liu G; Rusckowski M; Vanderheyden JL
    Nucl Med Biol; 2006 Feb; 33(2):263-9. PubMed ID: 16546682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies.
    Pearson DA; Lister-James J; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Taylor JE; Moyer BR; Dean RT
    J Med Chem; 1996 Mar; 39(7):1361-71. PubMed ID: 8691466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor targeting with hydrophilic [
    Makris G; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma.
    Friebe M; Mahmood A; Bolzati C; Drews A; Johannsen B; Eisenhut M; Kraemer D; Davison A; Jones AG
    J Med Chem; 2001 Sep; 44(19):3132-40. PubMed ID: 11543682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.
    Jiménez-Mancilla N; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Isaac-Olivé K; Camacho-López M; Torres-García E
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):663-71. PubMed ID: 25196028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.
    Makris G; Tseligka ED; Pirmettis I; Papadopoulos MS; Vizirianakis IS; Papagiannopoulou D
    Mol Pharm; 2016 Jul; 13(7):2301-17. PubMed ID: 27170456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
    Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides.
    Sanders VA; Iskhakov D; Abdel-Atti D; Devany M; Neary MC; Czerwinski KR; Francesconi LC
    Nucl Med Biol; 2019; 68-69():1-13. PubMed ID: 30578134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
    Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
    Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.